2Berry,R. E.,& Boland,J. P. (1977). The economic cost of alcohol abuse. New York: The Free Press.
3Colishaw, N. E.,& Myers,G. (1984). Dollar estimates of the consequences of tobacco use in Canada, 1979. Canadian Journal of Public Health,75,192-199.
4Collins,D.,& Lapsley,H. (1994). Technical issues in abuse cost estimation. In International guidelines for estimating the costs of substance abuse. Unpublished Paper.
5Easton,B.,(1994). A layperson guide to the evaluation of social and economic costs of substance abuse. In International guidelines for estimating the costs of substance abuse.Unpublished Paper.
6Harwood,H., (1994). Selected issues and parametres in the design and performance of costs of illness studies for substance abuse. In International guidelines for estimating the costs of substance abuse. Unpublished Paper.
7Single,E.,et al. (1994). International guidelines for estimating the costs of substance abuse. Unpublished Paper.
同被引文献60
1Remington PL Brownson RC, Wegner MV. Chronic disease epidemiology and control[ M ]. Washington I).C: American Public Health Association, 2010:2-4.
2Nissinen A, Tuomilehto J, Kottke TE, et al. Cost-effectiveness of the North Karelia Hypertension Program 1972-1977 [ J ]. Med Care, 1986,24(8):767-780.
3Jousilahti P, Laatikainen T, Peltonen M, et al. forty-year change in coronary heart disease mortality among working aged men and women in eastern finland: the role of primary prevention and risk factor reduction[ J ]. Circulation, 2014,130(suppl 2):A11878.
4Puska P. Prevention of cardiovascular diseases: a spearhead for control of noncommunicable diseases [J ]. East Mediterr Health J, 2014, 20 ( 7 ):407-408..
5Baxter T, Milner P, Wilson K, et al. A cost effective, community based heart health promotion project in England: prospective comparative study[ J ]. BMJ, 1997, 315(7108):582-585.
6Lindholm L, Rosen M, Weinchall L, et al. Cost-effectiveness and equity of a community based cardiovascular disease prevention programme in NorsjG Sweden[J ]. J Epidemiol Cominunity Health, 1996,50(2):190-195.
7Stern MP, Brown BW, Haskell WL, et al.Cardiovascular risk and use of estrogens or estrogen-progestagen combinations: Stanford three- community study [ J ].JAMA, 1976,235 ( 8 ) :811-815.
8Fortmann SP, Flora JA, Winkleby MA, et al. Community intervention trials: reflections on the Stanford Five-City Project experience [J]. Am J Epidemiol, 1995,142(6):576-586.
9Tosteson AN, Weinstein MC, Hunink MG, et al. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels[ J ]. Circulation, 1997,95( 1 ):24-30.
10Investigators WMPP. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration [ J ]. J Clin Epidemiol, 1988,41(2): 105-114.
